Samsung Biologics' Product Carbon Footprint system received independent validation, enabling accurate carbon data for client products and supporting sustainable supply chains.
This validation is crucial for Samsung Biologics' clients, particularly those operating within or exporting to regions with stringent environmental regulations and growing consumer demand for sustainable products. It enables them to accurately assess and report the environmental impact of their biologics, facilitating greener supply chain decisions and potentially offering a competitive advantage in the APAC market. The company's proactive approach to carbon accounting sets a benchmark for the industry.
Samsung Biologics' PCF system validated by an independent expert.
Enables accurate carbon footprint data for client products.
Enhances climate transparency and supports sustainable supply chains.
As a leading biopharmaceutical CDMO in APAC, Samsung Biologics' commitment to climate transparency through validated carbon footprinting directly impacts its regional clients and partners. This initiative aligns with growing ESG expectations across Asia, influencing supply chain sustainability and corporate responsibility standards within the sector.
Enhances climate transparency and supports sustainable supply chains.
Demonstrates leadership in environmental responsibility within the biopharma sector.
Sign in to save notes on signals.
Sign In